These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31148182)

  • 21. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA; Wu LT; Cheng KC; Ko WC; Chuang YC; Yu WL
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of the antibiotic resistant gene in multidrug-resistant Enterobacter cloacae isolated at Showa University Hospital].
    Takahashi N; Yamaguchi F; Chen G; Yasuhara T; Ito R; Wakuta R; Fukuchi K
    Rinsho Byori; 2010 May; 58(5):442-7. PubMed ID: 20560453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHV-12 extended spectrum beta-lactamase associated with high-level ceftazidime resistance in Enterobacter cloacae isolated from Thailand.
    Tansawai U; Boonkerd N; Polwichai P; Dejsirilert S; Niumsup PR
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):148-54. PubMed ID: 19323047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergism between WLBU2 peptide and antibiotics against methicillin-resistant Staphylococcus aureus and extended-spectrum beta-lactamase-producing Enterobacter cloacae.
    Elsalem L; Al Sheboul S; Khasawneh A
    J Appl Biomed; 2021 Mar; 19(1):14-25. PubMed ID: 34907712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).
    Miltgen G; Bonnin RA; Avril C; Benoit-Cattin T; Martak D; Leclaire A; Traversier N; Roquebert B; Jaffar-Bandjee MC; Lugagne N; Filleul L; Subiros M; de Montera AM; Cholley P; Thouverez M; Dortet L; Bertrand X; Naas T; Hocquet D; Belmonte O
    Int J Antimicrob Agents; 2018 Sep; 52(3):416-420. PubMed ID: 29807164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic and biochemical characterisation of CTX-M-37 extended-spectrum β-lactamase from an Enterobacter cloacae clinical isolate from Mongolia.
    Lee K; Yong D; Jeong SH; Tulgaa K; Docquier JD; Rossolini GM; Chong Y
    J Glob Antimicrob Resist; 2017 Sep; 10():3-7. PubMed ID: 28587869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of avibactam against Enterobacter cloacae producing an extended-spectrum class C β-lactamase enzyme.
    Lahiri SD; Giacobbe RA; Johnstone MR; Alm RA
    J Antimicrob Chemother; 2014 Nov; 69(11):2942-6. PubMed ID: 24986496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of colistin sulfate against Enterobacteriaceae producing extended-spectrum β-lactamases.
    Ku YH; Lee MF; Chuang YC; Chen CC; Yu WL
    J Microbiol Immunol Infect; 2015 Dec; 48(6):699-702. PubMed ID: 24388585
    [TBL] [Abstract][Full Text] [Related]  

  • 29. soxRS induces colistin hetero-resistance in Enterobacter asburiae and Enterobacter cloacae by regulating the acrAB-tolC efflux pump.
    Telke AA; Olaitan AO; Morand S; Rolain JM
    J Antimicrob Chemother; 2017 Oct; 72(10):2715-2721. PubMed ID: 29091215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First identification of an IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae in China.
    Huang L; Wang X; Feng Y; Xie Y; Xie L; Zong Z
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():51. PubMed ID: 26607057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Imidazole Aldoximes with Broad-Spectrum Antimicrobial Potency against Multidrug Resistant Gram-Negative Bacteria.
    Skočibušić M; Odžak R; Ramić A; Smolić T; Hrenar T; Primožič I
    Molecules; 2018 May; 23(5):. PubMed ID: 29783685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic Effect of Colistin Combined with PFK-158 against Colistin-Resistant Enterobacteriaceae.
    Zhang Y; Wang X; Li X; Dong L; Hu X; Nie T; Lu Y; Lu X; Pang J; Li G; Yang X; Li C; You X
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro resistance of Enterobacter cloacae isolated from fresh seafood to colistin.
    Almeida MVA; Brito ILP; Carvalho ALS; Costa RA
    Rev Soc Bras Med Trop; 2018; 51(5):674-675. PubMed ID: 30304276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic response of β-lactamases-producing Enterobacter cloacae complex strain to cefotaxime-induced stress.
    Maravić A; Cvjetan S; Konta M; Ladouce R; Martín FA
    Pathog Dis; 2016 Jul; 74(5):. PubMed ID: 27162211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity of ceftazidime-avibactam and comparator agents when tested against bacterial isolates causing infection in cancer patients (2013-2014).
    Sader HS; Castanheira M; Jones RN; Flamm RK
    Diagn Microbiol Infect Dis; 2017 Mar; 87(3):261-265. PubMed ID: 28069328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of a carbapenem-resistant and colistin-heteroresistant Enterobacter cloacae clinical isolate in Japan.
    Uechi K; Tada T; Shimada K; Nakasone I; Kirikae T; Fujita J
    J Infect Chemother; 2019 Apr; 25(4):285-288. PubMed ID: 30279112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The pharmacodynamics of avibactam in combination with ceftaroline or ceftazidime against β-lactamase-producing Enterobacteriaceae studied in an in vitro model of infection.
    MacGowan A; Tomaselli S; Noel A; Bowker K
    J Antimicrob Chemother; 2017 Mar; 72(3):762-769. PubMed ID: 28039276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterisation and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan.
    Yu WL; Cheng KC; Chi CJ; Chen HE; Chuang YC; Wu LT
    Clin Microbiol Infect; 2006 Jun; 12(6):579-82. PubMed ID: 16700709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro synergistic activity of colistin and ceftazidime or ciprofloxacin against multidrug-resistant clinical strains of Pseudomonas aeruginosa.
    D'Souza BB; Padmaraj SR; Rekha PD; Tellis RC; Prabhu S; Pothen P
    Microb Drug Resist; 2014 Dec; 20(6):550-4. PubMed ID: 25055029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.